Baxalta Incorporated
Baxalta Incorporated, a leading biopharmaceutical company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 2015, Baxalta emerged from a spin-off of Baxter International, focusing on innovative therapies for rare diseases and complex conditions. The company is renowned for its specialised products in haemophilia, immunology, and oncology, with offerings such as Adynovate, a unique recombinant factor VIII therapy that enhances patient outcomes.
Baxalta has established a strong market position, recognised for its commitment to research and development, which has led to significant advancements in treatment options. With a dedication to improving patient lives, Baxalta continues to be a key player in the biopharmaceutical industry, striving for excellence in every aspect of its operations.
+38 vs industry average
Baxalta Incorporated’s score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Baxalta Incorporated?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Baxalta Incorporated yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Baxalta Incorporated’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Baxalta Incorporated yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Takeda Pharmaceutical Company Limited
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Takeda Pharmaceutical Company LimitedRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project